NASDAQ:TSVT - US9013841070 - Common Stock
Overall TSVT gets a fundamental rating of 3 out of 10. We evaluated TSVT against 547 industry peers in the Biotechnology industry. TSVT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TSVT is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -11.94% | ||
ROE | -27.16% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 52.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -1.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.67 | ||
Quick Ratio | 4.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
5
+0.01 (+0.2%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 7.03 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.26 | ||
P/tB | 1.3 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -11.94% | ||
ROE | -27.16% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 52.43% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 9.96% | ||
Cap/Sales | 1.87% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 4.67 | ||
Quick Ratio | 4.67 | ||
Altman-Z | -1.3 |